Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy
Cancer Letters · 2025-11 · 633 · 218012
DOI: 10.1016/j.canlet.2025.218012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-11. Verfasst von Yingying Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, 201508, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, Neoplasms, Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Shanghai City Science and Technology Commission, China Postdoctoral Science Foundation, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Single-cell RNA sequencing (scRNA-seq) has emerged as a transformative technology for unraveling the cellular complexity and architecture of diseased tissues. By capturing the transcriptomic profiles of individual cells, scRNA-seq reveals intra-tumoral heterogeneity, distinct immune cell states, and dynamic intercellular interactions, making it particularly valuable in the study of the tumor immune microenvironment (TIME). In recent years, scRNA-seq has been widely adopted in both basic cancer research and clinical applications, advancing our understanding of tumor development, immune regulation, and therapy resistance. These advances have also driven the evolution of computational tools and analytical methods needed to interpret complex scRNA-seq datasets to support the development of precision diagnostics. This review systematically summarizes the core analytical workflows for scRNA-seq data, outlines best practices in data processing, and explores the emerging applications and challenges of this technology in TIME research and translational oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
- Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, 201508, China; Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Ed…
Förderung
- Shanghai City Science and Technology Commission
- China Postdoctoral Science Foundation
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Huang, Y., Zhang, M., & Gao, Q. (2025). Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy. Cancer Letters, 633, 218012. https://doi.org/10.1016/j.canlet.2025.218012
Vancouver
Huang Y, Zhang M, Gao Q. Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy. Cancer Letters. 2025;633:218012. doi:10.1016/j.canlet.2025.218012
BibTeX
@article{Huang2025,
author = {Huang, Yingying and Zhang, Mao and Gao, Qiang},
title = {Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy},
journal = {Cancer Letters},
year = {2025},
volume = {633},
pages = {218012},
doi = {10.1016/j.canlet.2025.218012}
}
EUVIMED